Stonepine Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$698K	Sell	491,300 -36,542	-7%	-$51.9K	0.68%	35
2025 Q1	$2.77M	Sell	527,842 -135,563	-20%	-$710K	2.69%	13
2024 Q4	$1.65M	Sell	663,405 -1,795,468	-73%	-$4.45M	1.33%	23
2024 Q3	$2.83M	Buy	2,458,873 +531,427	+28%	+$611K	1.79%	19
2024 Q2	$2.12M	Buy	+1,927,446	New	+$2.12M	1.93%	11